Normal view MARC view ISBD view

Corticosteroids in the treatment of optic neuritis. [electronic resource]

By:

Achiron, A

Contributor(s):

Producer: 19920730Description: 281-2 p. digitalISSN:

0028-4793

Subject(s):

In: The New England journal of medicine vol. 327

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Letter

There are no comments on this title.

to post a comment.

Back to results

1 [Pyorrhea].
by MERINO, J F
2 Immediate or emergency tooth extraction.
by MERINO, J F
3 [Vitamin E in the treatment of pyorrhea alveolaris].
by MERINO, J F
4 [Is there a cure for pyorrhea? Reflections on a ticklish subject and rejection of a negativistic and routine work].
by MERINO, J F
5 [Vitamin E in pyorrhea alveolaris].
by MERINO, J F
6 Normoglycemia restores beta-cell replicative response to glucose in transplanted islets exposed to chronic hyperglycemia.
by Nacher, V
7 [Treatment plan # 3. Emergency/acute care unit].
by Roldán Merino, J F
8 Donor-derived Strongyloides stercoralis hyperinfection syndrome after simultaneous kidney/pancreas transplantation.
by Galiano, A
9 Optimal insulin treatment in syngeneic islet transplantation.
by Merino, J F
10 Preserved beta cell function with insulin treatment in islet transplantation: effect on insulin gene expression.
by Raurell, M
11 Beta-cell growth and mass are preserved in long-term syngeneic islet transplantation in streptozocin-induced diabetic Lewis rats.
by Nácher, V
12 Improved outcome of islet transplantation in insulin-treated diabetic mice: effects on beta-cell mass and function.
by Merino, J F
13 Plasma lipids and blood fluidity in patients with polygenic hypercholesterolaemia treated with fluvastatin.
by Piñon, F
14 Influence of age on clinical and immunological characteristics of newly diagnosed type 1 diabetic patients.
by Fajardo, C
15 Ketoacidosis at diagnosis is predictive of lower residual beta-cell function and poor metabolic control in type 1 diabetes.
by Fernandez Castañer, M